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Abstract
This review addresses three main questions: (1)Why is anorectal sensory function important in humans? (2)What is the evidence
for anorectal sensory dysfunction in disease? (3) Can anorectal sensory function be modified for therapeutic benefit?
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Introduction
Why is anorectal sensory function important
in humans?
Humans have what is termed a social pattern of defaecation,
i.e. one that delays bowel opening until a convenient moment
and acceptable location, e.g. a toilet. This rather obvious re-
mark has importance since it underpins the concept that
humans require conscious perception of the need to defaecate
with sufficient advanced warning such that social defaecation
can be planned and executed. This function has evolved in
humans and also exists in primates and other mammals that
live in closed quarters, e.g. dogs, cats and even rodents (see
James Jones review in this Festschrift). It is not present in
more primitive eukaryotes, e.g. worms, nor, it would appear,
in unconfined animals that graze, e.g. ungulates. This makes
teleological sense in terms of spread of disease, etc.
Conscious perception implies sensory connectivity be-
tween the main organ of faecal storage (the rectum) and the
brain. The detailed anatomy of the nervous system in respect
of this function is incompletely understood in higher mam-
mals and difficult to study in small experimental animals, e.g.
rat and guinea pig because of translational differences, e.g.
rodents have no specified division between colon and rectum.
Nevertheless, the following points can be summarised:
& Afferent nerve endings relevant to defaecation reside not
only in the rectum but also in the upper anal canal where
they may ‘sample’ rectal contents [1]. In addition to relay-
ing conscious discrimination of rectal contents, such end-
ings are also probably critical to the reflex maintenance of
continence (not covered in this review).
& Sensory endings must be able to not only detect dis-
tension (stretching or pressure) but also distinguish
faecal contents (solid, liquid and air). The latter func-
tion underpins the ability to selectively detect and pass
flatus and may be mediated by multimodal endings
such as those responding to temperature and chemicals
(taste) as well as pressure.
& Pressure and stretch receptors are located in the myenteric
plexus as intraganglionic laminar endings (IGLEs) and
signal via pelvic parasympathetic nerves [2, 3]. It is not
known whether the muscularis propria also has intramus-
cular arrays (IMAs). Thermosensory and chemosensory
functions are probably mediated by free nerve endings in
the mucosa and submucosa and probably signal via spinal
nerves. This organisation is in keeping with the much
better studied upper GI tract where physiological func-
tions such as proprioception are mainlymediated via vagal
rather than spinal innervation.
& Somatic nerve endings contribute to distal rectal and upper
anal sensory function via the pudendal nerve [4].
Regardless of the above, it is a fact that all sensory nerves
must reach the spinal cord and thence the brain to sub-serve
perception and these do so by following the vasculature in
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keeping with all other areas of the mesenteric innervation.
Having crossed the mesorectum, such nerves all reach the
posterior pelvis and pelvic side walls to join the dense plexus
over the sacrum (the pudendal nerves lie below the pelvic
floor and other nerves above). This anatomy is precarious in
the sense that it is subject to compression and stretching of the
pelvic floor and side walls such as occurs in pregnancy and
childbirth (but also probably in prolonged straining and mor-
bid obesity). The strong epidemiological link between preg-
nancy and childbirth and defaecatory disorders (especially
faecal incontinence) is very well established [5] and has been
shown to be in part mediated by nerve injury (with a focus on
the pudendal nerves) [6, 7].
What is the evidence for anorectal sensory
dysfunction in disease?
There is clear evidence that disturbances of anorectal sensa-
tion are associated with a variety of diseases. This section will
mainly focus on defaecatory disorders (constipation and faecal
incontinence). Such evidence comes from three main sources:
Patient reporting
While this is often overlooked in favour of objective measure-
ments, it is well known that many patients readily volunteer
symptoms that attest to loss or gain in sensory perception. In
patients with chronic constipation, it is not uncommon to find
patients with no spontaneous urge to defaecate. Such patients
are dependent thence on digitally assessing the rectum and
aiding evacuation with manual measures or enemas; this defi-
ciency is embodied within the ‘spontaneous complete bowel
movement’ outcome measure used in some major pharmaco-
logical trials [8]. Other patients, for instance those with faecal
incontinence, have a late or extreme urge to defaecate. Such
‘urgency’may lead to frank incontinence if toilet facilities are
distant. The time between first urge and involuntary passage
of stool can be recorded as the deferment time and may be
reduced to a few minutes in patients with faecal incontinence
(FI) in contrast to healthy adults where (in the absence of acute
diarrhoeal illness) most can defer days if necessary [9].
Finally, many patients describe an abnormal urge to defaecate
with feelings of abdominal cramps rather than a pressure or
fullness in the pelvis. An instrument to record five sequential
defaecations in terms of visceral sensation has been recently
developed and shows such differences between disease and
health in adults and children (http://www.gastrojournal.org/
article/S0016-5085(16)33164-X/abstract).
Standard (clinical) tests of anorectal sensation
The principle of distending the rectum to evoke perception of
filling was first introduced by Goligher and Hughes in 1951
[10]. Studies of disease have demonstrated rectal hypersensi-
tivity in patients with IBS in 1973 [11] and colitis in 1978
[12]. Subsequent studies of patients with constipation and
incontinence show a proportion of patients with blunted sen-
sation (rectal hyposensation) [13–15]. A plethora of further
studies have confirmed these findings, especially in IBS
where visceral hypersensitivity is now considered a biomarker
of the condition.
Methodologically, rectal distension can be performed using
a simple syringe and balloon catheter assembly [15] or a elec-
tromechanical barostat [16]. A full discussion of the pros and
cons of these two approaches can be found elsewhere [17]. In
brief, both depend on evaluating the patient’s threshold for
first constant sensation, defaecatory desire and maximum tol-
eration. Barometric distension is considered more valid and
yields additional variables such as compliance of the rectal
wall. It does so however at considerable cost in terms of in-
vestigation time, patient acceptability and complexity of pro-
tocols (ramp vs. phasic distension; methods of levels or
limits). While a new ‘rapid barostat’ may change practice,
most specialist centres currently employ volumetric distension
only or reserve barostat protocols for specific patients. A fur-
ther issue of both methods is the delineation of normality with
little international consensus on the relative significance of
single or multiple threshold abnormalities. Nevertheless,
Table 1 summarises data using rectal sensory testing in main
patient groups.
Advanced (research) tests of anorectal sensory pathways
In this Festschrift collection, Professor Jones’ preceding re-
view introduced an animal model in which somatosensory-
evoked (using anal electrical stimulation) brain activity could
be disrupted by pelvic nerve compression injury. In patients
with FI, a small number of electrophysiological studies have
suggested blunting of anal electrical sensation [18]. Also, pro-
longation of evoked potential latencies has been demonstrated
using pudendal electrical stimulation [19] or rapid balloon
rectal and anal distensions [20]. Collaborative studies of pa-
tients with FI from our own group (QMUL) and UCD dem-
onstrate a disruption in somatosensory pathways from the anal
canal that is almost identical to that observed in our rodent
Table 1 Summary of rectal sensory findings in disease based on
summation of data from published literature using a variety of methods
(see text)
Condition Hypersensitivity Hyposensitivity
Irritable bowel syndrome 40–90% 15%
Chronic constipation 5% 25%
Faecal incontinence 30% 10%
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model of pelvic nerve injury. Interestingly, this finding was
limited to parous females [unpublished data]. In patients with
chronic constipation and rectal hyposensitivity, prolongation
of latencies to rectal (electrical) evoked potentials has also
been demonstrated [21].
In parallel, dynamic brain imaging techniques have been
applied extensively to visceral evoked activities in patients
with IBS using either PETor fMRI [22]. No studies of similar
quality have yet been performed in patients with incontinence
or constipation.
Can anorectal sensory function be modified
for therapeutic benefit?
The principle of modulating anal or rectal sensory functions
for therapeutic benefit is well engrained by reconditioning
techniques such as biofeedback where sensory training can
be used to recognise smaller distensions and/or to re-
coordinate rectal contraction concomitant with sensation of
rectal filling [17]. Aside from this, the medical (non-
surgical) literature is mainly limited to the suppression of vis-
ceral hypersensitivity in patients with abdominal pain, espe-
cially in relation to IBS [23]. There is currently no established
medical therapy for treating visceral hyposensitivity, and re-
markably, it remains unclear whether other drugs, for instance
opioids, can induce rectal hyposensitivity despite their obvi-
ous role in inducing conditions associated with blunted rectal
sensation, i.e. chronic constipation.
In contrast, the surgery literature is well served by studies
that have investigated the effect of sacral neuromodulation
(SNM) on anorectal sensory function. SNM is now the first
line surgical intervention for patients failing non-surgical treat-
ments for FI. Relatively early on in the evolving literature
concerning SNM efficacy, reports of restoration of patient
self-reported sensory functions, and increased deferment times
[24] were augmented by observations of improved (more nor-
malised) sensory thresholds to balloon distensions [25]. Many
studies now confirm this observation using both volumetric
and barostatic methods [36]. These include two small double-
blind randomised trials performed during the percutaneous
nerve evaluation stage of SNM [26, 27]. Indeed, restoration
of rectal sensory function is the only physiological effect to
have been independently confirmed in randomised blinded
study designs and accords with urological (bladder) literature
derived from both experimental animals and man [28, 29].
The effect of SNM on normalising (anal) somatosensory
evoked potentials in a rodent model of nerve injury is covered
in the review by James Jones (this series). In humans, SNM
was found to cause a small though statistically significant
reduction in latency using pudendal electrical stimulation
[19] A paucity of data also exist for anal sensation [20]
and fo r b ra in imag ing (h t tp : / /www. i s rc tn . com/
ISRCTN98760715). A large NIHR-funded European trial of
SNM efficacy and mechanism (including UCD) [the
SUBSONiC study] will use magneticoencepalography [col-
laborating with the Aston Brain Centre] to study patients with
FI undergoing SNM or sham stimulation to resolve both tem-
poral and spatial resolution of cortical and subcortical re-
sponses alongside changes in symptoms [30].
These observations are not simply an intellectual curi-
osity. SNM, although currently pre-eminent as a safe and
effective treatment for adults with severe FI, is not a pan-
acea. It is recognised that more accurate prediction of
responders vs. non-responders would allay ongoing con-
cerns regarding long-term effectiveness and cost. The
problem of patient selection is highlighted by ‘indecision’
in recent international guidelines [31] where patients with
evidence of sphincter injury can be considered suitable for
sphincter repair or SNM. It is clear that patients with
high-grade obstetric sphincter trauma and immediate on-
set of symptoms, and also those with a cloacal defect,
should be offered some form of repair and perineal recon-
struction. However, these form the small minority of pa-
tients in colorectal surgical practice. Rather, the majority
are women who develop symptoms much later in life (af-
ter childbirth), e.g. in their 50s and 60s. A high proportion
of such women will have some form of sphincter defect/
deficiency/scarring based on imaging with endo-anal ul-
trasound [32] but this is probably a minor contributor (or
even bystander) to their functional deficit based on epide-
miological data [5, 33]. Rather, these patients have a path-
ophysiology whose main contributors are pudendal and
pelvic autonomic neuropathy, as well as endo-pelvic fas-
cial and ligamentous injuries. The latter are detectable by
clinical examination and imaging as pelvic organ prolapse
syndromes and (when deemed significant) should be pri-
marily corrected ahead of other interventions for FI [31].
The former however are difficult to detect reliably with
routinely available tests (e.g. pudendal nerve terminal mo-
tor latencies). That is, unless one considers anorectal sen-
sory testing as a marker of global pelvic nerve injury,
which might not only detract the surgeon from performing
a sphincter repair but also push decision-making toward
SNM (based on above data). While difficult to prove de-
finitively (this would require a trial with a stratified med-
icine design), some thought should also be given to
whether this brings back into consideration (after failure
of two RCTs to show benefit of SNM over sham stimula-
tion in patients with chronic constipation in general [34,
35]) a group of patients (with rectal hyposensation) whose
main symptoms are those of rectal evacuation rather than
incontinence [26], i.e. a phenotype akin to ‘Fowler’s syn-
drome’ of the bladder (which responds preferentially to
SNM [27]).
In summary, anorectal sensory function is important in
humans and is evidenced by both clinical observations and
Ir J Med Sci (2018) 187:1143–1147 1145
specialist objective tests. While research is ongoing, it would
appear that anorectal sensory function is modifiable in associ-
ation with therapeutic benefit and may function as a future
stratifier for clinical decision making.
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